These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 6779147

  • 1. [Fluspirilen and fluphenazine in schizophrenic patients. Comparative study].
    Magnus RV.
    MMW Munch Med Wochenschr; 1980 Dec 05; 122(49):1758-60. PubMed ID: 6779147
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F.
    Act Nerv Super (Praha); 1974 Aug 05; 16(3):167-8. PubMed ID: 4607824
    [No Abstract] [Full Text] [Related]

  • 5. A controlled clinical trial of fluspirilene, a long-acting injectable neuroleptic, in schizophrenic patients with acute exacerbation.
    Chouinard G, Annable L, Steinberg S.
    J Clin Psychopharmacol; 1986 Feb 05; 6(1):21-6. PubMed ID: 3512622
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Current status of neuroleptic long term treatment of schizophrenia].
    Woggon B, Angst J, Margoses N.
    Nervenarzt; 1975 Nov 05; 46(11):611-6. PubMed ID: 813157
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fluspirilene: a long-acting injectable neuroleptic.
    Drug Ther Bull; 1977 Jul 22; 15(15):59-60. PubMed ID: 330126
    [No Abstract] [Full Text] [Related]

  • 12. The problem of post-psychotic schizophrenic depressions and their pharmacological induction. Long-term studies with fluspirilene and penfluridol and single-blind trial with fluphenazine-decanoate and flupenthixol-decanoate.
    Floru L, Heinrich K, Wittek F.
    Int Pharmacopsychiatry; 1975 Jul 22; 10(4):230-9. PubMed ID: 814106
    [Abstract] [Full Text] [Related]

  • 13. [Prognostic significance of selected side effects occurring in the course of prolonged-action fluphenazine treatment].
    Koślacz A, Popkowska N, Kulesza E, Lysikowska-Prokop L, Marmurowska-Michalowska H, Perzyński J.
    Psychiatr Pol; 1977 Jul 22; 11(2):159-64. PubMed ID: 887674
    [No Abstract] [Full Text] [Related]

  • 14. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G, Annable L, Ross-Chouinard A.
    Am J Psychiatry; 1982 Mar 22; 139(3):312-8. PubMed ID: 6120655
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J, Woggon B.
    Arzneimittelforschung; 1975 Feb 22; 25(2):267-70. PubMed ID: 1091272
    [Abstract] [Full Text] [Related]

  • 16. A retrospective evaluation of long-term fluspirilene (IMAP) treatment.
    Tanghe A.
    Acta Psychiatr Belg; 1976 May 22; 76(3):480-90. PubMed ID: 1020683
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Continued ambulatory therapy of schizophrenic patients using injectable delayed-action neuroleptic drugs].
    Hartmann W, Müller P.
    Dtsch Med Wochenschr; 1972 Aug 25; 97(34):1255-7. PubMed ID: 5048319
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
    Odejide OA, Aderounmu AF.
    J Clin Psychiatry; 1982 May 25; 43(5):195-6. PubMed ID: 7076630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.